Clinical Chemistry 1993-02-01

Assessment and optimization of kinetic methods for angiotensin-converting enzyme in plasma.

J E Buttery, S Stuart

Index: Clin. Chem. 39(2) , 312-6, (1993)

Full Text: HTML

Abstract

In the kinetic angiotensin-converting enzyme (ACE) method, a practical and optimal buffer is 80 mmol/L borate buffer at pH 8.2 (37 degrees C). A lag phase is detected in the reaction, and a 5-min incubation of substrate and plasma is suggested before the kinetic measurement. The substrate, N-[3-(2-furyl)acryloyl]-L-phenylalanylglycylglycine (FAPGG), concentration is maximized at 1.0 mmol/L and the measurement wavelength is at 345 nm to ensure linearity of measurement. The proposed procedure uses a 1:9 plasma-to-reagent volume ratio. The linear range of the assay extends to approximately 170 U/L, representing a 25% substrate hydrolysis. The FAPGG absorptivity is determined by measuring the difference in absorbance between 1.0 mmol/L FAPGG and the product solutions. The wavelength fidelity is checked by noting the expected absorbance value of the FAPGG solution, and a 1.0-nm deviation from 345 nm alters the absorbance by 15.5%. The precision of ACE assays at approximately 60 and 100 U/L is 3.5% and 2.4% within batch and 2.9% and 2.6% between batch, respectively. The reference interval (2.5th to 97.5th percentiles) is 41-139 U/L, and there is no difference between values for men and women.


Related Compounds

Related Articles:

Effect of power ultrasound pretreatment on peptidic profiles and angiotensin converting enzyme inhibition of milk protein concentrate hydrolysates.

2014-09-01

[J. Sci. Food Agric. 94(12) , 2420-8, (2014)]

Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme.

2003-08-28

[FEBS Lett. 550(1-3) , 84-8, (2003)]

Angiotensin-converting enzyme determination in plasma during therapy with converting enzyme inhibitor: two methods compared.

1991-08-01

[Clin. Chem. 37(8) , 1390-3, (1991)]

Determination of enzyme (angiotensin convertase) inhibitors based on enzymatic reaction followed by HPLC.

2001-03-01

[J. Pharm. Biomed. Anal. 24(5-6) , 1151-6, (2001)]

Physiological and enzymatic properties of the ram epididymal soluble form of germinal angiotensin I-converting enzyme.

2001-11-01

[Biol. Reprod. 65(5) , 1332-9, (2001)]

More Articles...